VRTX

Recent Articles

50 Ways to Make Market Swings Work For You

With the stock market moving around in earnings season, now is the time to look through our buy and sell chart looking for ways to maximize your upside More 

Bull’s Eye Report: Regeneron Pharmaceuticals (REGN)

Looking for a non-correlated asset to beat the market in a potential downturn? Look no further than biotech stock Regeneron Pharmaceuticals (REGN). More 

4 Attractive Biopharma Stocks of All Sizes

Biopharma is a high-growth niche in a defensive sector, but you need to balance risk with reward. Here are four hot biopharma stocks of different sizes. More 

Volatile Biotech Could Give Your Portfolio a Boost

Buy Vertex Pharmaceuticals on declines using a limit order price of $46. More 

9 Biotech Buyout Players to Watch

The deal between Human Genome Sciences and GlaxoSmithKline is just the most recent of big pharma buyouts -- and these biotech players could be next. More 

Top 6 Stocks to Buy for July

This month’s emphasis is on stocks that should do well despite near-term market concerns. More 

Clinical Trial Error Sends Vertex Shares Down

Vertex Pharmaceuticals saw its shares drop more than 14% in Tuesday trading on news of a mistake in clinical trials of its new cystic fibrosis treatments. More